H. Sakurai, Megha Nagaswami, Emily Tan, Ashley K Meyer, C. Streeter, F. Jain, Simmie L. Foster, A. Yeung, C. Cusin, M. Fava, D. Mischoulon, M. Nyer
{"title":"A Patient with Treatment-resistant Depression Who Achieved Remission with Heated Yoga: A Case Report","authors":"H. Sakurai, Megha Nagaswami, Emily Tan, Ashley K Meyer, C. Streeter, F. Jain, Simmie L. Foster, A. Yeung, C. Cusin, M. Fava, D. Mischoulon, M. Nyer","doi":"10.5234/cnpt.12.12","DOIUrl":null,"url":null,"abstract":"Novel interventions are needed to manage treatment-resistant depression (TRD), defined as patients who do not respond to two or more antidepressant trials of adequate dose and duration. We report on a 28-year-old female with TRD with nonresponse to several adequate trials of antidepressants who experienced full symptomatic remission after participating in the heated hatha yoga (HY) arm of a randomized controlled trial (RCT) for depression. Patients, including the one of interest, were randomized to 8 weeks of at least twice weekly HY or an 8-week waitlist followed by 8 weeks of HY. HY incorporates yoga plus heat through a se-ries of standardized poses performed in a heated room (105 °F ). The 30-item Inventory of Depressive Symptoms, Clinician-Rated (IDS-C 30 ) and 28-item Hamilton Depression Rating Scale (HAM-D 28 ) were assessed at key time points throughout the study. The patient attended 16 classes over 8 weeks. Her baseline IDS-C 30 score of 42 decreased to 26 following 2 weeks of HY, and continued declining throughout the intervention, with a final score of 6 (remission) after 8 weeks. HAM-D 28 scores decreased from 26 at baseline to 4 (remission) after 8 weeks. At the 1-month follow-up, the patient’s scores remained stable at 4 on IDS-C 30 and 7 on HAM-D 28 , respectively. HY may serve as a potential intervention for TRD in patients who have not previously responded to conventional antidepressants. The rigorousness of the intervention must be con-sidered regarding recommendations for use in the general population.","PeriodicalId":120512,"journal":{"name":"Clinical Neuropsychopharmacology and Therapeutics","volume":"153 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neuropsychopharmacology and Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5234/cnpt.12.12","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Novel interventions are needed to manage treatment-resistant depression (TRD), defined as patients who do not respond to two or more antidepressant trials of adequate dose and duration. We report on a 28-year-old female with TRD with nonresponse to several adequate trials of antidepressants who experienced full symptomatic remission after participating in the heated hatha yoga (HY) arm of a randomized controlled trial (RCT) for depression. Patients, including the one of interest, were randomized to 8 weeks of at least twice weekly HY or an 8-week waitlist followed by 8 weeks of HY. HY incorporates yoga plus heat through a se-ries of standardized poses performed in a heated room (105 °F ). The 30-item Inventory of Depressive Symptoms, Clinician-Rated (IDS-C 30 ) and 28-item Hamilton Depression Rating Scale (HAM-D 28 ) were assessed at key time points throughout the study. The patient attended 16 classes over 8 weeks. Her baseline IDS-C 30 score of 42 decreased to 26 following 2 weeks of HY, and continued declining throughout the intervention, with a final score of 6 (remission) after 8 weeks. HAM-D 28 scores decreased from 26 at baseline to 4 (remission) after 8 weeks. At the 1-month follow-up, the patient’s scores remained stable at 4 on IDS-C 30 and 7 on HAM-D 28 , respectively. HY may serve as a potential intervention for TRD in patients who have not previously responded to conventional antidepressants. The rigorousness of the intervention must be con-sidered regarding recommendations for use in the general population.